VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $688,896 | -10.6% | 25,600 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $770,816 | -6.9% | 25,600 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $828,160 | +337.8% | 25,600 | +287.9% | 0.00% | +300.0% |
Q4 2022 | $189,156 | +130.7% | 6,600 | +94.1% | 0.00% | 0.0% |
Q3 2022 | $82,000 | -81.5% | 3,400 | -79.0% | 0.00% | -66.7% |
Q2 2022 | $444,000 | -81.6% | 16,200 | -74.2% | 0.00% | -76.9% |
Q1 2022 | $2,408,000 | +79.8% | 62,770 | +83.5% | 0.01% | +30.0% |
Q3 2020 | $1,339,000 | +227.4% | 34,200 | +92.4% | 0.01% | +150.0% |
Q1 2020 | $409,000 | -81.7% | 17,779 | -78.8% | 0.00% | -81.0% |
Q3 2019 | $2,236,000 | -13.2% | 83,697 | -17.0% | 0.02% | -16.0% |
Q2 2019 | $2,576,000 | -1.6% | 100,800 | -13.7% | 0.02% | -3.8% |
Q1 2019 | $2,619,000 | – | 116,800 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |